KLOTHO NEUROSCIENCES INC (KLTO) Stock Income Statement
USA - NASDAQ:KLTO - US49876K1034 - Common Stock
0.4716 USD
+0.01 (+1.53%)
0.4558 USD
-0.02 (-3.35%)
| TTM (2025-6-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | |||
| Gross Premiums Earned | null | null | null | null | null | |||
| Loss Claims | null | null | null | null | null | |||
| Deferred Policy Acquisition Expense | null | null | null | null | null | |||
| Net Interest Income | null | null | null | null | null | |||
| Non Interest Income | null | null | null | null | null | |||
| Loan Loss Provision | null | null | null | null | null | |||
| Net Interest Income after Provision | null | null | null | null | null | |||
| Non Interest Expense | null | null | null | null | null | |||
| Minority Interest Expense | null | null | null | null | null | |||
| Cost Of Goods | null | null | null | null | null | |||
| Gross Profit | null | null | null | null | null | |||
| Operating Expenses | 8.20M | 5.54M | 1.30M | 660.00K | 0 | |||
| Research and Development | null | null | null | null | null | |||
| Selling, General, and Administrative Expenses | 9.89M | 5.54M | 1.30M | 660.00K | null | |||
| Operating Income | -8.20M | -5.54M | -1.30M | -660.00K | 0 | |||
| Interest Income/Expense | -2.66M | -356.60K | 3.36M | 1.58M | null | |||
| Other Income/Expense | -47.10K | -253.50K | -26.50K | 560.00K | null | |||
| Non Recurring Items | null | null | null | null | null | |||
| Income Before Taxes | -11.35M | -6.15M | 2.04M | 1.48M | 0 | |||
| Income Tax | null | 0 | 690.60K | 240.00K | null | |||
| Net Income | -11.35M | -6.15M | 1.35M | 1.23M | 0 | |||
| EBITDA | null | undefined | undefined | undefined | undefined | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.45499999999999996 | -0.3195 | 0.138 | 0.1 | 0 | |||
| Non GAAP EPS | null | null | null | null | null | |||
| Statistics | ||||||||
All data in USD